» Articles » PMID: 36060047

One-year Outcomes Following Internal Ligation Suture Removal in 350 Mm Baerveldt Tube Implant Surgery

Overview
Date 2022 Sep 5
PMID 36060047
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: Long-term data of the postoperative management following Baerveldt tube surgery (BVT) is currently limited. This study aims to evaluate the outcome and the safety profile of internal ligation suture removal after BVT surgery for refractory glaucoma.

Materials And Methods: A prospective, consecutive, non-comparative case series of patients previously undergoing BVT 350 mm surgery with 0.4 mg/mL mitomycin C (MMC), 3/0 intraluminal suture (Supramid) insertion, and 10/0 nylon external ligation suture(s). For each patient, data was collected over 12 months after internal ligation suture removal. Follow-up assessments looked at intraocular pressure (IOP), complication rate, and postoperative number of glaucoma medications. Definition of success was adopted as per the World Glaucoma Association recommendations.

Results: Twenty-four patients were included. On average, Supramid was removed at 22 ± 18.2 weeks following BVT surgery. Preoperatively, the mean IOP was 30.9 ± 12.6 mm Hg and the average antiglaucoma medications were 1.95 ± 1.13. At 12 months, the mean IOP was 15.2 ± 5.3 mm Hg and the mean number of glaucoma medications was 1.3 ± 0.2. Qualified success with IOP ≤ 21 mm Hg and IOP ≤ 15 mm Hg was achieved in 62.5% and 33.3%, respectively. Only two patients developed hypotony following Supramid removal; both resolved spontaneously within 1 month.

Conclusion: Our results show a good IOP reduction and safety profile at 1 year from internal ligation suture removal following BVT. A drop in IOP of approximately 50% from the preoperative IOP can be expected.

How To Cite This Article: Stringa F, Chen R, Agrawal P. One-year Outcomes Following Internal Ligation Suture Removal in 350 mm Baerveldt Tube Implant Surgery. J Curr Glaucoma Pract 2022;16(1):20-23.

References
1.
Lloyd M, Baerveldt G, Heuer D, Minckler D, Martone J . Initial clinical experience with the baerveldt implant in complicated glaucomas. Ophthalmology. 1994; 101(4):640-50. DOI: 10.1016/s0161-6420(94)31283-8. View

2.
SHERWOOD M, Smith M . Prevention of early hypotony associated with Molteno implants by a new occluding stent technique. Ophthalmology. 1993; 100(1):85-90. DOI: 10.1016/s0161-6420(93)31688-x. View

3.
Gedde S, Chen P, Heuer D, Singh K, Wright M, Feuer W . The Primary Tube Versus Trabeculectomy Study: Methodology of a Multicenter Randomized Clinical Trial Comparing Tube Shunt Surgery and Trabeculectomy with Mitomycin C. Ophthalmology. 2017; 125(5):774-781. PMC: 9289720. DOI: 10.1016/j.ophtha.2017.10.037. View

4.
Desai M, Gedde S, Feuer W, Shi W, Chen P, Parrish 2nd R . Practice preferences for glaucoma surgery: a survey of the American Glaucoma Society in 2008. Ophthalmic Surg Lasers Imaging. 2011; 42(3):202-8. DOI: 10.3928/15428877-20110224-04. View

5.
Gedde S, Schiffman J, Feuer W, Herndon L, Brandt J, Budenz D . Three-year follow-up of the tube versus trabeculectomy study. Am J Ophthalmol. 2009; 148(5):670-84. DOI: 10.1016/j.ajo.2009.06.018. View